200 related articles for article (PubMed ID: 17318862)
1. Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation.
Yi NJ; Suh KS; Cho JY; Kwon CH; Lee KW; Joh JW; Lee SK; Kim SI; Lee KU
Liver Transpl; 2007 Mar; 13(3):451-8. PubMed ID: 17318862
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
[TBL] [Abstract][Full Text] [Related]
4. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
[TBL] [Abstract][Full Text] [Related]
5. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
[TBL] [Abstract][Full Text] [Related]
6. Section 14. Combination of entecavir plus low-dose on-demand hepatitis B immunoglobulin is effective with very low hepatitis B recurrence after liver transplantation.
Hu TH; Chen CL; Lin CC; Wang CC; Chiu KW; Yong CC; Liu YW; Eng HL
Transplantation; 2014 Apr; 97 Suppl 8():S53-9. PubMed ID: 24849836
[TBL] [Abstract][Full Text] [Related]
7. [17-year study on the curative effect of treatment to prevent the recurrence of hepatitis B in different risk groups after liver transplantation].
Zhang DL; He X; Feng DN; Ren MJ; Guang YH; Li LX; Wang HB; Liu ZW
Zhonghua Gan Zang Bing Za Zhi; 2024 Jan; 32(1):22-28. PubMed ID: 38320787
[No Abstract] [Full Text] [Related]
8. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
Akyildiz M; Karasu Z; Zeytunlu M; Aydin U; Ozacar T; Kilic M
J Gastroenterol Hepatol; 2007 Dec; 22(12):2130-4. PubMed ID: 18031370
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience.
Akcam AT; Ulku A; Rencuzogullari A; Eray IC; Okoh A; Kuran S; Dalcı K; Yalav O; Parsak CK; Sakman G; Demiryurek H
Transplant Proc; 2015 Jun; 47(5):1445-9. PubMed ID: 26093739
[TBL] [Abstract][Full Text] [Related]
10. [Liver transplantation for chronic hepatitis B patients with lamivudine monotherapy or lamivudine combined with individualized low-dose hepatitis B immunoglobulin treatment].
Jiao ZY; Yan LN; Li B; Zeng Y; Wen TF; Lu SC; Zhao JC; Wang WT; Xu MQ; Yang JY; Li ZH; Ma YK; Zhang ZW; Chen ZY
Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):804-8. PubMed ID: 18073060
[TBL] [Abstract][Full Text] [Related]
11. Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow-up study.
Xie SB; Zhu JY; Ying Z; Zeng LJ; Chao M; Lu MQ
Transplantation; 2010 Oct; 90(7):786-90. PubMed ID: 20703179
[TBL] [Abstract][Full Text] [Related]
12. Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy.
Wong SN; Chu CJ; Wai CT; Howell T; Moore C; Fontana RJ; Lok AS
Liver Transpl; 2007 Mar; 13(3):374-81. PubMed ID: 17318855
[TBL] [Abstract][Full Text] [Related]
13. Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation.
Na GH; Kim DG; Han JH; Kim EY; Lee SH; Hong TH; You YK; Choi JY
J Gastroenterol Hepatol; 2014 Jan; 29(1):151-6. PubMed ID: 24117684
[TBL] [Abstract][Full Text] [Related]
14. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
[TBL] [Abstract][Full Text] [Related]
15. Evolving experience of hepatitis B virus prophylaxis in liver transplantation.
Honaker MR; Shokouh-Amiri MH; Vera SR; Alloway RR; Grewal HP; Hardinger KL; Kizilisik AT; Bagous T; Trofe J; Stratta RJ; Egidi MF; Gaber AO
Transpl Infect Dis; 2002 Sep; 4(3):137-43. PubMed ID: 12421458
[TBL] [Abstract][Full Text] [Related]
16. Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis.
Katz LH; Paul M; Guy DG; Tur-Kaspa R
Transpl Infect Dis; 2010 Aug; 12(4):292-308. PubMed ID: 20002355
[TBL] [Abstract][Full Text] [Related]
17. Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.
Karasu Z; Ozacar T; Akyildiz M; Demirbas T; Arikan C; Kobat A; Akarca U; Ersoz G; Gunsar F; Batur Y; Kilic M; Tokat Y
Antivir Ther; 2004 Dec; 9(6):921-7. PubMed ID: 15651751
[TBL] [Abstract][Full Text] [Related]
18. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
Dodson SF; de Vera ME; Bonham CA; Geller DA; Rakela J; Fung JJ
Liver Transpl; 2000 Jul; 6(4):434-9. PubMed ID: 10915164
[TBL] [Abstract][Full Text] [Related]
19. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
Takaki A; Yagi T; Iwasaki Y; Sadamori H; Matsukawa H; Matsuda H; Shinoura S; Umeda Y; Miyake Y; Terada R; Kobashi H; Sakaguchi K; Tanaka N; Shiratori Y
Transplantation; 2007 Jan; 83(2):231-3. PubMed ID: 17264822
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years.
Yilmaz N; Shiffman ML; Todd Stravitz R; Sterling RK; Luketic VA; Sanyal AJ; Maluf D; Coterell A; Posner MP; Fisher RA
Liver Int; 2008 Jan; 28(1):72-8. PubMed ID: 17983429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]